A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

Clinical trial NCT05509985 · UNKNOWN

Trial details

NCT number: NCT05509985
Sponsor: AskGene Pharma, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-08-09
Primary completion: 2023-09-09
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.